Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Hand hygiene01:23

Hand hygiene

Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bintrafusp alfa for patients with recurrent or metastatic olfactory neuroblastoma.

Cancer immunology, immunotherapy : CII·2026
Same author

Expansion of pathogens and restoration of human skin microbiome in CD4 T-cell lymphopenia.

The Journal of investigative dermatology·2026
Same author

Merkel cell carcinoma virus positivity ranges from 57% to 77% in the United States based on geographic region: A pooled cohort study.

Journal of the American Academy of Dermatology·2026
Same author

Immunotherapy Significantly Improves Merkel Cell Carcinoma-Specific Survival: A Single-Cohort Propensity Score-Matched Analysis.

medRxiv : the preprint server for health sciences·2026
Same author

It Mite Not Be Graft-Versus-Host Disease: Frequency and Clinical Features of Demodex Folliculitis After Allogeneic Hematopoietic Cell Transplantation.

Transplantation and cellular therapy·2026
Same author

Epidermotropic Metastatic Melanoma Presenting as Eruptive Primary Melanomas.

Pigment cell & melanoma research·2026

Related Experiment Video

Updated: Jul 8, 2026

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

Update on pemphigus treatment: present and future.

Isaac Brownell

    Journal of Drugs in Dermatology : JDD
    |January 15, 2008
    PubMed
    Summary

    Pemphigus management necessitates long-term systemic therapies with no current standard of care. Ongoing research explores treatment efficacy and the potential of p38MAPK pathway inhibitors for new therapeutic strategies.

    Area of Science:

    • Autoimmune blistering diseases
    • Dermatology
    • Immunology

    Background:

    • Pemphigus management requires prolonged systemic therapy.
    • Current treatment protocols lack standardization, presenting varied efficacy and risks.
    • Recent clinical trials have not established a universally superior treatment regimen.

    Discussion:

    • Evaluating the efficacy of diverse pemphigus treatment regimens is crucial.
    • Understanding the risks and benefits associated with each therapeutic approach is essential.
    • The role of p38MAPK in pemphigus pathogenesis is an area of active investigation.

    Key Insights:

    • No single pemphigus treatment protocol is definitively superior.
    • Systemic therapies are vital for pemphigus management but carry risks.

    Related Experiment Videos

    Last Updated: Jul 8, 2026

    Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
    05:05

    Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

    Published on: June 17, 2025

  • Advances in understanding pemphigus are paving the way for novel treatments.

    • Outlook:

    • Future pemphigus therapies may target the p38MAPK pathway.
    • Continued research aims to define optimal treatment strategies for pemphigus.
    • Personalized medicine approaches may improve pemphigus management outcomes.